Cargando…
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
Clozapine is the most effective medication for treatment-resistant psychosis, but evidence points to substantial underuse, especially within early intervention psychosis (EIP) services. We explored clinicians’ views on perceived barriers and facilitators to offering patients clozapine within EIP ser...
Autores principales: | Oloyede, Ebenezer, Blackman, Graham, Mantell, Bethany, Harris, Eleanor, Williams, Julie, Taylor, David, MacCabe, James, McGuire, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147630/ https://www.ncbi.nlm.nih.gov/pubmed/37117237 http://dx.doi.org/10.1038/s41537-023-00353-0 |
Ejemplares similares
-
Clozapine for treatment resistance in early psychosis: a survey of UK
clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022) -
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?
por: Blackman, Graham, et al.
Publicado: (2021) -
Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022) -
Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021) -
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)